Skip to main content
    R

    ResMed Inc (RMD)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $237.95
    -0.24 (-0.10%)

    Market Cap: $33.69B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    ResMed Inc (RMD) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    ResMed (RMD) has a latest price of $237.95 on Nov 17, 2026, 13.4% below its 52-week high of $274.65. Its price fell 2.1% over the past 12 months. The month-end price rose 284.7% over the 10 years through Oct 2026, a compound annual rate of 14.4%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $290.53 in Aug 2021 and its lowest $59.77 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RMD with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RMD.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 3.7%, and over 6 months it rose 14.9%. The month-end price rose 62.8% over the 3 years through Oct 2026, a compound annual rate of 17.6%.

    PeriodChange
    1 month-0.5%
    3 months+3.7%
    6 months+14.9%
    12 months-2.1%
    12 months, with dividends-1.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+62.8%+17.6%
    5 years-12.5%-2.6%
    10 years+284.7%+14.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 37.2%, and its weakest was 2022, when it fell 20.1%.

    YearCloseChange
    2026 through Oct 2026$229.94-4.5%
    2025$240.87+5.3%
    2024$228.69+32.9%
    2023$172.02-17.3%
    2022$208.13-20.1%
    2021$260.48+22.5%
    2020$212.56+37.2%
    2019$154.97+36.1%
    2018$113.87+34.5%
    2017$84.69+36.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.5% above its 50-day average of $232.10 and 6.8% above its 200-day average of $222.83.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$237.95
    52-week high$274.65-13.4%
    52-week low$179.26+32.7%
    50-day average$232.10+2.5%
    200-day average$222.83+6.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 37.5%.

    MeasureValue
    1-year beta0.49
    Largest fall, 1 year-33.6%
    Largest fall, 3 years-37.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    ResMed traded at 23.4x earnings at the end of 2025, against a 5-year median of 27.8x and a 10-year median of 30.0x.

    RMD valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RMD

    What is RMD's 1-year price change?

    ResMed's price fell 2.1% over the past 12 months. With dividends included, the 12-month total return was -1.1%.

    What is RMD's 5-year price change?

    ResMed's month-end price fell 12.5% over the 5 years through Oct 2026, a compound annual decline of 2.6%. These figures leave out dividends.

    What is RMD's 52-week high and low?

    ResMed's 52-week high is $274.65 and its 52-week low is $179.26. Its latest price of $237.95 on Nov 17, 2026 is 13.4% below the high.

    What is RMD's beta?

    ResMed's 1-year beta against the S&P 500 is 0.49, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 33.6%.

    Is the RMD chart free?

    Yes. Advanced Charting for RMD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.